Novavax, Inc.NVAXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-28.6%
5Y CAGR+2.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-28.6%/yr
vs +59.3%/yr prior
5Y CAGR
+2.2%/yr
Recent deceleration
Acceleration
-87.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $489.07M | -32.9% |
| 2024 | $728.35M | -6.5% |
| 2023 | $779.13M | -41.9% |
| 2022 | $1.34B | -28.8% |
| 2021 | $1.88B | +329.1% |
| 2020 | $439.11M | +196.2% |
| 2019 | $148.26M | -28.8% |
| 2018 | $208.21M | +2.6% |
| 2017 | $202.89M | -28.7% |
| 2016 | $284.47M | - |